Please login to the form below
Skin and Blister
This page shows the latest Skin and Blister news and features for those working in and with pharma, biotech and healthcare.
Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns
The condition is a life-threatening rare skin disease, which is incurable and causes the skin to blister due to a lack of collagen that renders the skin very fragile. ... This gene is missing in RDEB patients, and can restore normal collagen production
Latest news
-
New healthcare comms agency launched in UK
Skin and Blister co-founded by Fiona Edwards and Katie Langdon. Healthcare communications specialists Fiona Edwards and Katie Langdon have launched a new creative agency specialising in pharmaceutical marketing services. ... With Skin and Blister, you
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Skin and Blister Agency
Skin and Blister Agency.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- AstraZeneca’s mild combination asthma reliever approved in UK
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Italy accelerates the path towards digital therapeutics implementation
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Time to talk about health inequalities
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- The speed of science and the pace of comms
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
